Two-time major champion Dustin Johnson has signed a multi-year extension with LIV Golf ahead of the 2026 season, the league ...

There’s something undeniably special about going big for the people who mean the most to you. While thoughtful, budget-friendly gifts have their place, every once in a while, splurging on something ...

He's set to make $9 million in 2026 and $10 million in 2027. If they pick up his 2028 option, he'll make $7 million. The buyout for that option is $4 million, guaranteeing him at least $23 million. If ...

ORLANDO, Fla. – Steven Matz, who spent the second half of the ’25 season in the Red Sox bullpen, has a two-year deal with their division-rival Tampa Bay Rays, pending a physical. The veteran ...

SANTA CLARA, Calif., December 03, 2025--(BUSINESS WIRE)--Digitate, a leading global agentic AI platform provider for autonomous IT operations, today announced a bundled SaaS offering with BMC’s ...

WhatsApp has been working on a variety of features for the iOS users. Among those in the pipeline, WhatsApp has started rolling out a new TestFlight beta for iOS that brings native multi-account ...

Apple, Amazon, Lockheed Martin, Microsoft, Google, Coinbase, Comcast and Meta are just some of the major companies who have made donations to build President Donald Trump’s proposed 90,000-square-foot ...

Unity Software is rated a buy, positioned at an inflection point for double-digit growth, driven by its CS and GS segments and the Vector launch. U's new Vector AI ad platform is a game-changer, ...

Abstract: In this paper, we present a digital circuit of arithmetic unit implementing addition and subtraction operations in multiple-precision arithmetic (MPA). This adder-subtractor unit is a part ...

Multiple people were shot and injured at 345 Park Avenue in New York City, the location of NFL headquarters. The suspected shooter has been neutralized, according to NYPD Police Commissioner Jessica ...

Bristol Myers Squibb has ended its R&D losing streak with a hit on one of the dual primary endpoints in a phase 3 multiple myeloma trial. But with the study continuing to evaluate the other primary ...